Stocks in Hong Kong fluctuate | Quansys Biologics-B(02509.HK) surged more than 6% upon reaching an exclusive global licensing agreement with Roche for QX031N, with an initial payment of 75 million USD.

According to the Wise News Finance APP, Qunxing Biological-B (02509.HK) opened more than 6% higher, and as of the time of writing, it has risen by 6.49% to 26.9 Hong Kong dollars, with a turnover of 2.4049 million Hong Kong dollars.